Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris...

Cureus
24 January 2023
https://www.cureus.com/articles/132544-oral-low-dose-naltrexone-in-the-treatment-of-frontal-fibrosing-alopecia-and-lichen-planopilaris-an-uncontrolled-open-label-prospective-study#!/

How Long Does it Take Low Dose Naltrexone to Work?

The Enlightened Mindset
15 January 2023
https://www.lihpao.com/how-long-does-it-take-low-dose-naltrexone-to-work/

Fourteen Percent of Those Who Contracted COVID-19 Face Long-Term Challenges

Pharmacy Times
16 January 2023
https://www.pharmacytimes.com/view/fourteen-percent-of-those-who-contracted-covid-19-face-long-term-challenges

Clinicians Discuss Major Treatments for Long COVID–The Effective and the Questionable

The Epoch Times
02 January 2023
https://www.theepochtimes.com/health/clinicians-discuss-major-treatments-for-long-covid-the-effective-and-the-questionable_4950709.html

Fibromyalgia Year in Review: 2022

Rhematologynetwork.com
26 December 2022
https://www.rheumatologynetwork.com/view/fibromyalgia-year-in-review-2022

Researchers launch trial to treat long COVID with drug used to block effects of opioids

ABC Gold Coast
20 December 2022
https://www.abc.net.au/news/2022-12-21/long-covid-treatment-trial-drug-low-dose-naltrexone/101770626?utm_source=abc_news_web&utm_medium=content_shared&utm_campaign=abc_news_web

Are addiction drugs effective for COVID-19 sequelae? (In Japanese)

Tokyo Metropolitan Institute of Medical Sciences
06 December 2022
https://www.igakuken.or.jp/r-info/covid-19-info139.html

‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever

Pain News Network
15 November 2022
https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever

Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions

Medical Dialogues
15 November 2022
https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374